The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hematologic toxicities with axicabtagene ciloleucel for B cell lymphomas in a majority minority population.
 
Simran Arjani
No Relationships to Disclose
 
Bradley Rockwell
No Relationships to Disclose
 
Vita Berani
No Relationships to Disclose
 
Ahmed Abbasi
No Relationships to Disclose
 
Mendel Goldfinger
No Relationships to Disclose
 
Ioannis Mantzaris
Honoraria - Syndax
Travel, Accommodations, Expenses - Adaptive Biotechnologies
 
Aditi Shastri
Honoraria - Great Debates and Updates; Peerview
Consulting or Advisory Role - Kymera; Ryvu Therapeutics
Research Funding - Kymera; Ryvu Therapeutics
 
Kira Gritsman
Research Funding - ADC Therapeutics; iOnctura
 
Noah Kornblum
No Relationships to Disclose
 
David Levitz
No Relationships to Disclose
 
Lauren Shapiro
No Relationships to Disclose
 
Ridhi Gupta
No Relationships to Disclose
 
Stephen Peeke
No Relationships to Disclose
 
Jhannine Verceles
No Relationships to Disclose
 
Amanda Lombardo
No Relationships to Disclose
 
Marina Konopleva
Consulting or Advisory Role - Abbvie; AstraZeneca; Auxenion; BAKX Therapeutics; Boehringer Ingelheim; Dark Blue Therapeutics; F. Hoffmann LaRoche; Genentech; Gilead Sciences; Janssen; Legend Biotech; MEI Pharma; Redona Therapeutics; Sanofi; Sellas Life Sciences; Stemline Therapeutics; Vincerx Pharma
Research Funding - Abbvie; Allogene Therapeutics; AstraZeneca; Genentech; Gilead Sciences; ImmunoGen; MEI Pharma; Precision BioSciences; Rafael Pharmaceuticals; Sanofi; Stemline Therapeutics
Patents, Royalties, Other Intellectual Property - Lilly; Novartis; Reata Pharmaceuticals
 
Eric Feldman
No Relationships to Disclose
 
Amit Verma
Leadership - Cardiff Oncology (I); CytomX Therapeutics (I)
Stock and Other Ownership Interests - Roshon Therapeutics; Stelexis Therapeutics; ThromboGenics
Honoraria - Stelexis Therapeutics
Consulting or Advisory Role - Janssen; Keros Therapeutics; Ryvu Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Prelude Therapeutics; Ryvu Therapeutics
 
Dennis Cooper
No Relationships to Disclose
 
Alejandro Sica
No Relationships to Disclose